View source for CR:DOI:9001a5594f91dd6bf04eed25ac6ece98

{{#scite:
 |reference=menzies2018fo
 |type=article-journal
 |title=Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
 |author=Dick Menzies;Menonli Adjobimey;Rovina Ruslami;Anete Trajman;Oumou Sow;Heejin Kim;Joseph Obeng Baah;Guy B. Marks;Richard Long;Vernon Hoeppner;Kevin Elwood;Hamdan Al-Jahdali;Martin Gninafon;Lika Apriani;Raspati C. Koesoemadinata;Afranio Kritski;Valeria Rolla;Boubacar Bah;Alioune Camara;Isaac Boakye;Victoria J. Cook;Hazel Goldberg;Chantal Valiquette;Karen Hornby;Marie-Josée Dion;Pei-Zhi Li;Philip C. Hill;Kevin Schwartzman;Andrea Benedetti|+sep=;
 |journal=New England Journal of Medicine
 |publisher=Massachusetts Medical Society
 |year=2018
 |volume=379
 |issue=5
 |pages=440-453
 |doi=10.1056/nejmoa1714283
 |subject=General Medicine
 |issn=0028-4793;1533-4406|+sep=;
 |retrieved-from=https://dx.doi.org/
 |retrieved-on=2019-11-19
 |@show=true
}}